Pear Therapeutics Inc (PEAR) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Pear Therapeutics Inc   (NASDAQ: PEAR)


Pear Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PEAR Gross Profit Margin (Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4
Y / Y Revenue Change 94.32 %
Seq. Revenue Change -37.18 %
Revenue In Millions $2.57
Gross Profit Margin 31.97 %
Gross Profit Margin Total Ranking # 2694
Gross Profit In Millions $0.82
Y / Y Gross Profit Change -
Seq. Gross Profit Change -46.34 %


Commenting fourth quarter 2022 Gross Profit Margin
Pear Therapeutics Inc experienced contraction in Gross Profit by -46.34 % to $3 millions and Revenue by -37.18 %, while Gross Profit Margin fell to 31.97 %, below company*s average Gross Profit Margin.


Observing fourth quarter 2022 results within Medical Equipment & Supplies industry 167 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2398 to 2694.
Learn about Gross Margin
PEAR's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 168
Healthcare Sector # 467
Overall # 2647

Gross Profit Margin Statistics
High Average Low
46.13 % 35.67 % 27.18 %
(Mar 31 2022)   (Jun 30 2022)


PEAR Gross Income Trends • More of PEAR's Profitabilty Ratios • PEAR Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PEAR's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PEAR's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PEAR's Competitors
Gross Profit Margin Profit Margin for Pear Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for PEAR's Customers

You may also want to know
PEAR's Annual Growth Rates PEAR's Profitability Ratios PEAR's Asset Turnover Ratio PEAR's Dividend Growth
PEAR's Roe PEAR's Valuation Ratios PEAR's Financial Strength Ratios PEAR's Gross Profit Growth
PEAR's Roa PEAR's Inventory Turnover Ratio PEAR's Growth Rates PEAR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Medical Equipment & Supplies Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Shockwave Medical Inc   87.85 %$ 126.524  Millions$ 144.026  Millions
Inari Medical Inc   87.82 %$ 94.643  Millions$ 107.771  Millions
Vycor Medical Inc   86.30 %$ 0.234  Millions$ 0.271  Millions
Avita Medical Inc   85.75 %$ 8.108  Millions$ 9.455  Millions
Sanara Medtech Inc   84.53 %$ 12.947  Millions$ 15.316  Millions
Si bone inc   84.07 %$ 26.864  Millions$ 31.953  Millions
Inspire Medical Systems inc   83.94 %$ 115.748  Millions$ 137.900  Millions
Inmode Ltd   83.82 %$ 380.786  Millions$ 454.271  Millions
Fonar Corporation  83.41 %$ 20.233  Millions$ 24.256  Millions
Axogen inc   83.02 %$ 30.023  Millions$ 36.164  Millions
Nuo Therapeutics Inc   82.81 %$ 0.061  Millions$ 0.074  Millions
Sight Sciences Inc   82.17 %$ 16.880  Millions$ 20.544  Millions
Nexalin Technology Inc   82.11 %$ 0.032  Millions$ 0.038  Millions
Paragon 28 inc   81.97 %$ 42.221  Millions$ 51.508  Millions
Cerus Corporation  81.71 %$ 87.094  Millions$ 106.592  Millions
Edwards Lifesciences Corporation  80.87 %$ 1,090.400  Millions$ 1,348.300  Millions
Zynex inc   80.76 %$ 39.417  Millions$ 48.805  Millions
Mimedx Group Inc   80.68 %$ 60.006  Millions$ 74.375  Millions
Treace Medical Concepts Inc   80.43 %$ 40.027  Millions$ 49.769  Millions
Streamex Corp   80.00 %$ 0.108  Millions$ 0.135  Millions
Cvrx inc   78.97 %$ 5.667  Millions$ 7.176  Millions
Surmodics Inc   78.88 %$ 19.666  Millions$ 24.933  Millions
Electromedical Technologies Inc   78.68 %$ 0.333  Millions$ 0.423  Millions
Staar Surgical Co  77.74 %$ 49.785  Millions$ 64.044  Millions
Novocure Limited  77.51 %$ 99.541  Millions$ 128.429  Millions
Neuronetics Inc   75.88 %$ 13.809  Millions$ 18.198  Millions
Glaukos Corp  75.82 %$ 54.005  Millions$ 71.227  Millions
Iradimed Corporation  75.49 %$ 11.220  Millions$ 14.864  Millions
Electrocore Inc   75.00 %$ 1.920  Millions$ 2.560  Millions
Tela Bio Inc   74.92 %$ 8.176  Millions$ 10.913  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.